A randomized phase III study evaluating dexamethasone-based mouthwash to prevent chemotherapy-induced stomatitis in patients with breast cancer

被引：0

作者：

Kuba, Sayaka ^{[1
]}

Soutome, Sakiko ^{[2
]}

Hagiwara, Yasuhiro ^{[3
]}

Kikawa, Yuichiro ^{[4
]}

Iwamoto, Takayuki ^{[5
]}

Sangai, Takafumi ^{[6
]}

Harao, Michiko ^{[7
]}

Yamaguchi, Takeshi ^{[8
]}

Taji, Tomoe ^{[9
]}

Igarashi, Ataru ^{[10
]}

Kajimoto, Yusuke ^{[10
]}

Sakurai, Naomi ^{[11
]}

Yamanouchi, Kosho ^{[12
]}

Watanabe, Kenichi ^{[13
]}

Maeda, Noriko ^{[14
]}

Suzuki, Masahiko ^{[15
]}

Maeda, Shigeto ^{[16
]}

Toh, Uhi ^{[17
]}

Ebata, Akiko ^{[18
]}

Iwakuma, Nobutaka ^{[19
]}

Matsunuma, Ryoichi ^{[20
]}

Yamaguchi, Miki ^{[21
]}

Mukai, Hirofumi ^{[22
]}

机构：

[1] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, 1-7-1 Sakamoto, Nagasaki 8528102, Japan

[2] Nagasaki Univ, Grad Sch Biomed Sci, Dept Oral Hlth, 1-7-1 Sakamoto, Nagasaki 8528102, Japan

[3] Univ Tokyo, Grad Sch Med, Dept Biostat, 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan

[4] Kansai Med Univ Hosp, Dept Breast Surg, 3-1 Shinmachi 2 Chome, Hirakata, Osaka 5731191, Japan

[5] Kawasaki Med Sch Hosp, Breast & Thyroid Surg, 577 Matsushima, Kurashiki, Okayama 7010192, Japan

[6] Kitasato Univ, Sch Med, Dept Breast & Thyroid Surg, 1-15-1,Kitazato,Minami Ku, Sagamihara, Kanagawa 2520375, Japan

[7] Jichi Med Univ, Dept Breast Oncol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan

[8] Toranomon Gen Hosp, Dept Med Oncol, 2-2-2 Toranomon,Minato Ku, Tokyo 1058470, Japan

[9] Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Breast Surg, 17-77 Higashinanba Machi, Amagasaki, Hyogo 6608550, Japan

[10] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Econ & Outcomes Res, 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan

[11] Canc Solut Inc, Tokyo, Japan

[12] Nagasaki Harbor Med Ctr, Dept Breast & Endocrine Surg, 6-39 Shinchi Machi, Nagasaki 8508555, Japan

[13] NHO Hokkaido Canc Ctr, Dept Med Oncol, 1-1,5-7 Yamanote,Nishi Ku, Sapporo, Hokkaido 0630005, Japan

[14] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol Breast & Endocrine Surg, 1-1-1, MinamiKogushi, Ube, Yamaguchi 7558505, Japan

[15] Kitamurayama Hosp, Breast Ctr, 2-15-1,Onsen Machi, Yamagata 9993792, Japan

[16] Nagasaki Rosai Hosp, Dept Surg, 12-5,Setogoe 2 Chome, Sasebo, Nagasaki 8570134, Japan

[17] Kurume Univ Hosp, Dept Breast Surg, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan

[18] Tohoku Univ, Grad Sch Med, Dept Breast & Endocrine Surg Oncol, 2-1,Seiryo Machi,Aoba Ku, Sendai, Miyagi 9808575, Japan

[19] NHO Kyushu Med Ctr, Breast Ctr, Dept Breast Surg, 1-8-1 Chigyohama, Fukuoka 8108563, Japan

[20] Shizuoka Prefectural Gen Hosp, Dept Breast Surg, 4-27-1,Kita Ando Aoi Ku, Shizuoka 4208527, Japan

[21] JCHO Kurume Gen Hosp, Dept Breast Surg, 21 Kushihara Machi, Kurume, Fukuoka 8300013, Japan

[22] Natl Canc Ctr Hosp East, Dept Breast & Med Oncol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan

来源：

JAPANESE JOURNAL OF CLINICAL ONCOLOGY | 2024年

关键词：

stomatitis; chemotherapy; dexamethasone mouthwash; randomized controlled phase III trial; CYCLOPHOSPHAMIDE; EPIRUBICIN; DOCETAXEL; WOMEN;

D O I：

10.1093/jjco/hyae136

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Stomatitis, which is a common side effect of chemotherapy, currently lacks a standardized approach for its prevention. Therefore, this multicenter, randomized, open-label, controlled phase III trial aims to assess the efficacy and safety of a dexamethasone-based mouthwash for preventing chemotherapy-induced stomatitis in patients with early breast cancer. We will randomly assign 230 patients with early breast cancer scheduled to receive chemotherapy in a 1:1 ratio to either the dexamethasone-based mouthwash group (10 ml, 0.1 mg/ml; swish for 2 min and spit 4 times daily for 8 weeks) or the mouthwash-with-tap-water group. The incidence of stomatitis, measured using electronic patient-reported outcomes, is the primary endpoint. This randomized controlled phase III trial aims to evaluate the efficacy and safety of a dexamethasone-based mouthwash for preventing chemotherapy-induced stomatitis in patients with early breast cancer.

引用

页码：172 / 175

页数：6

共 50 条

[41] Evaluating Chemotherapy-induced Nausea and Vomiting and Food Intake in Patients With Gynecologic Cancer
Komatsu, Hiroaki
Oishi, Tetsuro
Sato, Shinya
Osaku, Daiken
Sawada, Mayumi
Kudoh, Akiko
Nonaka, Michiko
Sato, Seiya
Shimada, Muneaki
Itamochi, Hiroaki
Harada, Tasuku
ANTICANCER RESEARCH, 2019, 39 (08) : 4555 - 4560
[42] Effect of lithium on chemotherapy-induced neutropenia in Egyptian breast cancer patients; a prospective clinical study
Elkasar, Ahmed O.
Hussien, Fatma Z.
Abdel-Hamied, Hala E.
Saleh, Ibrahim G.
Mahgoup, Elsayed M.
El-Arabey, Amr A.
Abd-Allah, Adel R.
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 93 (06) : 541 - 554
[43] The Development and Testing of a Chemotherapy-Induced Phlebitis Severity (CIPS) Scale for Patients Receiving Anthracycline Chemotherapy for Breast Cancer
Harris, Valerie
Hughes, Meinir
Roberts, Rosie
Dolan, Gina
Williams, E. Mark
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (03)
[44] Effects of auricular acupressure on chemotherapy-induced nausea and vomiting in breast cancer patients: a preliminary randomized controlled trial
Jing-Yu Tan
Alex Molassiotis
Lorna K. P. Suen
Jian Liu
Tao Wang
Hui-Rong Huang
BMC Complementary Medicine and Therapies, 22
[45] Evaluating the total costs of chemotherapy-induced toxicity: Results from a pilot study with ovarian cancer patients
Calhoun, EA
Chang, CH
Welshman, EE
Fishman, DA
Lurain, JR
Bennett, CL
ONCOLOGIST, 2001, 6 (05) : 441 - 445
[46] Incidence of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer following adjuvant anthracycline and taxane
Okanami, Yuko
Ito, Yoshinori
Watanabe, Chie
Iijima, Kotaro
Iwase, Takuji
Tokudome, Nahomi
Takahashi, Shunji
Hatake, Kiyohiko
BREAST CANCER, 2011, 18 (03) : 182 - 188
[47] A phase III study evaluating oral glutamine and transforming growth factor-beta 2 on chemotherapy-induced toxicity in patients with digestive neoplasm
Khemissa, Faiza
Mineur, Laurent
Amsellem, Caroline
Assenat, Eric
Ramdani, Mohamed
Bachmann, Patrick
Janiszewski, Chloe
Cristiani, Isabelle
Collin, Fideline
Courraud, Julie
de Forges, Helene
Dechelotte, Pierre
Senesse, Pierre
DIGESTIVE AND LIVER DISEASE, 2016, 48 (03) : 327 - 332
[48] Incidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and navelbine in younger breast cancer patients
Wen-Bin Zhou
Hong Yin
Xiao-An Liu
Xiao-Ming Zha
Lin Chen
Jun-Cheng Dai
Ai-di Tao
Ling Chen
Jing-Jing Ma
Li-Jun Ling
Shui Wang
BMC Cancer, 10
[49] Effects of auricular acupressure on chemotherapy-induced nausea and vomiting in breast cancer patients: a preliminary randomized controlled trial
Tan, Jing-Yu
Molassiotis, Alex
Suen, Lorna K. P.
Liu, Jian
Wang, Tao
Huang, Hui-Rong
BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2022, 22 (01)
[50] Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trial
de Gregorio, Amelie
Haberle, Lothar
Fasching, Peter A.
Mueller, Volkmar
Schrader, Iris
Lorenz, Ralf
Forstbauer, Helmut
Friedl, Thomas W. P.
Bauer, Emanuel
de Gregorio, Nikolaus
Deniz, Miriam
Fink, Visnja
Bekes, Inga
Andergassen, Ulrich
Schneeweiss, Andreas
Tesch, Hans
Mahner, Sven
Brucker, Sara Y.
Blohmer, Jens-Uwe
Fehm, Tanja N.
Heinrich, Georg
Lato, Krisztian
Beckmann, Matthias W.
Rack, Brigitte
Janni, Wolfgang
BREAST CANCER RESEARCH, 2020, 22 (01)

← 1 2 3 4 5 →